INAMED CORP
10-Q/A, 1996-04-04
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Previous: XEROX CORP, DEF 14A, 1996-04-04
Next: IAI INVESTMENT FUND I INC, 497, 1996-04-04



<PAGE>

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------

                          SECURITIES AND EXCHANGE COMMISSION

                                Washington D.C. 20549

                              -------------------------


                                     FORM 10-Q/A-1


             FORM 10-Q/A QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                                          OF
                       THE SECURITIES AND EXCHANGE ACT OF 1934


FOR THE QUARTER ENDED SEPTEMBER 30, 1995          COMMISSION FILE NUMBER: 0-7101


                              -------------------------


                                  INAMED CORPORATION

State of Incorporation: Florida   I.R.S. Employer Identification No.: 59-0920629

           3800 Howard Hughes Parkway, Suite #900, Las Vegas, Nevada 89109

                           Telephone Number: (702) 791-3388

                              -------------------------

              Indicate by check mark whether the Registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.   Yes   X    No
                                                -----     -----


                              -------------------------


On September 30, 1995 there were 7,677,617 Shares of the Registrant's Common
                                  Stock Outstanding.

                           This document contains 3 pages.

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------

<PAGE>

                         INAMED CORPORATION AND SUBSIDIARIES
                             CONSOLIDATED BALANCE SHEETS

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                             (UNAUDITED)
                                          SEPTEMBER 30, 1995        DECEMBER 31, 1994
                                          ------------------        -----------------

    LIABILITIES AND STOCKHOLDERS' EQUITY
<S>                                      <C>                       <C>
Current liabilities:
  Current installments of long-
  term debt                              $      21,715               $     176,910
  Notes payable to bank                      1,795,543                   1,795,721
  Related party notes payable                1,084,814                     970,610
  Accounts payable                          16,289,799                  15,780,050
  Accrued liabilities:
     Salaries and wages                      5,972,023                   2,251,275
     Interest                                  566,338                     567,365
     Self-insurance                          1,237,032                   1,291,605
     Stock option compensation                  68,714                      68,714
     Other                                   2,990,602                   3,593,024
  Royalties payable                          1,975,580                   1,053,888
  Income taxes payable                       4,349,931                   4,960,352
  Deferred income taxes                        109,995                     335,777
                                          ------------                ------------

      Total current liabilities             36,462,086                  32,845,291
                                          ------------                ------------
Long-term debt, excluding current
   installments                                 39,325                      50,801



Deferred grant income                        1,026,595                     931,387

Deferred income taxes                          945,067                     352,115

Litigation settlement                        9,152,000                   9,152,000

Net stockholders' equity:
    Common stock, $0.01 par value
       Authorized 20,000,000 shares;
       issued and outstanding 7,677,617         76,776                      74,662
    Additional paid-in capital              10,071,635                   9,699,345
    Cumulative translation adjustment          997,719                     437,683
    Accumulated deficit                     (4,440,507)                 (5,732,863)
                                          ------------                ------------

      Net stockholders' equity               6,705,623                   4,478,827


  Commitments and contingencies           ------------                -------------

                                         $  54,330,696               $  47,810,401
                                          ------------                ------------
                                          ------------                ------------

</TABLE>

       The Notes to Financial Statements are an integral part of this statement.


                                     - 4 -

<PAGE>

                            INAMED CORPORATION

                                SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                             INAMED CORPORATION


                                             By  /s/Michael D. Farney
                                               ---------------------------------
                                               Michael D. Farney
                                               Chief Executive Officer and
                                               Chief Financial Officer



Dated: April 3, 1996
       ---------------------------


                                      -15-




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission